Senior insider sale
Chief Executive Officer at MINERALYS THERAPEUTICS, INC. — senior position signals high conviction
$4.35M
165.73K shares
CONGLETON JON plans to sell 165.73K shares of MINERALYS THERAPEUTICS, INC. valued at approximately $4.35M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Vesting of restricted share unit award
Granted as part of issuer equity compensation plan
Vesting of restricted share unit award
Granted as part of issuer equity compensation plan
Vesting of restricted share unit award
Granted as part of issuer equity compensation plan
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/10/2025 | Vesting of restricted share unit award Granted as part of issuer equity compensation plan | 14.43K | — |
10/10/2024 | Vesting of restricted share unit award Granted as part of issuer equity compensation plan | 35.95K | — |
7/10/2024 | Vesting of restricted share unit award Granted as part of issuer equity compensation plan | 24.62K | — |
| Total | 75K | ||
Completed
Units to sell
15.73K
Market value
$422.0K
Units to sell
75K
Market value
$1.97M
Planned — Approximate Date
Units to sell
75K
Market value
$1.96M
Units
165.73K
Value
$4.35M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/13/2026 | 15.73K | $422.0K | — | Completed |
3/31/2026 | 75K | $1.97M | — | Completed |
| Planned — Approximate Date | ||||
6/30/2026 | 75K | $1.96M | NASDAQ | Planned |
| Total | 165.73K | $4.35M | ||